“Pfizer had clues its blockbuster drug could prevent Alzheimer’s. Why didn’t it tell the world?”

Jon Baron points to this news article by Christopher Rowland: Pfizer had clues its blockbuster drug could prevent Alzheimer’s. Why didn’t it tell the world? A team of researchers inside Pfizer made a startling find in 2015: The company’s blockbuster rheumatoid arthritis therapy Enbrel, a powerful anti-inflammatory drug, appeared to reduce the risk of Alzheimer’s …